☆ 4.7 Article

LBA42OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO)

ANNALS OF ONCOLOGY (2018)

Journal

ANNALS OF ONCOLOGY

Volume 29, Issue suppl_8, Pages -

Publisher

Oxford University Press (OUP)

DOI: 10.1093/annonc/mdy424.052

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.